Alaska Health Center COVID-19 Survey Summary Report

Latest data from October 8, 2021

Number of Health Center respondents = 14 (52% of all Health Centers)

Data represents information provided by health centers from a single, specified reporting date. Summary information across report dates is not comparable due to differences in which health centers responded for a given report date.

Patients Tested

Metrics Value
Patients Tested for COVID-19, Virus Detection (PCR, antigen)1 6,321
Racial and/or Ethnic Minority Patients Tested for COVID-19, Virus Detection (PCR, antigen) 71.71%
Patients Tested Positive for COVID-19, Virus Detection (PCR, antigen)1 407
Racial and/or Ethnic Minority Patients Tested Positive for COVID-19, Virus Detection (PCR, antigen) 66.86%

Patients by Race and Ethnicity

Race/Ethnicity Patients Tested, Virus Detection (PCR, antigen)2 Patients Tested Positive, Virus Detection (PCR, antigen)2
White, Non-Hispanic/Latino Patients 24.82% 28.75%
White, Hispanic/Latino Patients 0.82% 0.98%
Black/African American, Non-Hispanic/Latino Patients 0.49% 1.97%
Black/African American, Hispanic/Latino Patients 0.06% 0.00%
Asian Patients3 2.18% 3.19%
American Indian/Alaska Native Patients3 57.03% 44.72%
Native Hawaiian/Other Pacific Islander Patients3 0.60% 4.67%
Patients with More than one race3 1.41% 1.72%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 0.32% 0.74%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 1.09% 1.72%
Unreported/Refused to Report Race and Ethnicity 11.17% 11.55%

Patients Vaccinated

Metrics Value
COVID-19 Immunization Series Initiated 206
Racial and/or Ethnic Minority Patients Who Initiated COVID-19 Immunization 48.61%
COVID-19 Immunization Series Completed 284
Racial and/or Ethnic Minority Patients Who Completed COVID-19 Immunization 37.19%
COVID-19 Immunization Series Additional 666
Racial and/or Ethnic Minority Patients Who Received an Additional Dose of COVID-19 Vaccine 77.08%

Vaccinations by Race and Ethnicity

Race/Ethnicity Patient COVID-19 Immunization Series Initiated2 Patient COVID-19 Immunization Series Completed2 Patient COVID-19 Immunization Series Additional2
White, Non-Hispanic/Latino Patients 35.92% 44.01% 19.07%
White, Hispanic/Latino Patients 1.94% 0.70% 2.55%
Black/African American, Non-Hispanic/Latino Patients 6.80% 0.35% 0.00%
Black/African American, Hispanic/Latino Patients 0.49% 0.00% 0.00%
Asian Patients3 10.19% 4.93% 0.75%
American Indian/Alaska Native Patients3 12.62% 16.90% 58.41%
Native Hawaiian/Other Pacific Islander Patients3 0.49% 0.00% 0.00%
Patients with More than one race3 0.00% 1.06% 2.25%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 1.46% 2.11% 0.15%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 3.40% 1.41% 1.35%
Unreported/Refused to Report Race and Ethnicity 26.70% 28.52% 15.47%

Testing Logistics

Average Turnaround Time for COVID-19 Test Results, Virus Detection (PCR, antigen)

Metrics Value
Less Than 1 Hour 35.71%
1 to 24 Hours 35.71%
More Than 24 Hours 28.57%
N/A 0.00%

Vaccine Logistics

Challenges in Deploying the COVID Vaccine

Metrics Value
Financial reimbursement for costs associated with vaccine administration 7.14%
Staffing to administer the vaccine 50.00%
Vaccine confidence 35.71%
Vaccine storage capacity 0.00%
Vaccine supply 7.14%
Other 0.00%
None 35.71%

Operations and Staff

Metrics Value
COVID-19 Vaccine Doses Received Only From Health Center COVID-19 Vaccine Program 0.00%
Average Percent of Health Center Visits Conducted Virtually 15.36%

Mobile Vans, Pop-Up Clinics, and School-Based Sites

Metrics Value
Percent of Health Centers Hosting Mobile Vans, Pop-Up, and/or School-Based Clinics 14.29%
Number of Mobile Van Sites 2
Number of Pop-up Clinics 15
Number of School-Based Vaccination Sites 9

Monoclonal Antibody Therapy

Methods in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Direct provision of monoclonal antibody therapies 50.00%
Refer patients to another organization that provides monoclonal antibody therapies 35.71%
None 21.43%

Challenges in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Access to therapeutics 7.14%
Patient awareness/education 0.00%
Staffing capacity 14.29%
Therapy administration/onsite logistics 0.00%
Other 7.14%
None 78.57%

1 The reported number of patients tested do not represent the same patients included in the reported number of patients tested positive due to a lag between the date the specimen is collected and the availability of test results. Positivity rates cannot be inferred by dividing patients tested positive by patients tested for this reason.

2 Percentages may not add to 100% due to rounding to the hundredths.

3 Includes Hispanic/Latino and Non-Hispanic/Latino.

Date Last Reviewed:  October 2021